Moderna's personalized melanoma vaccine just posted positive late-stage results alongside Merck, yet shares keep sliding ...
A late-stage melanoma vaccine report that was posted online and quickly pulled is driving a violent repricing in Moderna ...
This company made headlines with its coronavirus vaccine.
Moderna and Merck are preparing to seek regulatory approval after their experimental melanoma vaccine delivered promising ...
The U.S. Food and Drug Administration has approved on Thursday updated COVID-19 vaccines from Moderna Inc. MRNA, Pfizer Inc. PFE and BioNTech SE BNTX, and Sanofi SNY and Novavax Inc. NVAX for the 2026 ...
Vaccine stocks are cracking under intense selling pressure, and one small developer with no control over its own commercial ...
Dozens of Americans are rolling up their sleeves for a third dose of COVID-19 vaccine-- this time, shots tweaked to guard against a worrisome mutated version of the virus. “We need to be ahead of the ...
Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike ...
The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech, and Novavax. The agency gave a green light to supplemental biologics license ...
A federal judge in Delaware on Monday rejected Pfizer , BioNTech and Moderna's requests to dismiss patent lawsuits filed against them by Bayer's Monsanto unit over the messenger RNA technology used ...
9don MSN
Head-to-head comparison of three mRNA vaccines reveals differences in their stability in human blood
A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results